Industry News
ECLIPSE study demonstrates efficacy of Shield blood-based test for colorectal cancer screening
Study shows blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90%
News & Articles
25
Study shows blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90%